Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Launches the GEM DR model 7271 full-featured, dual chamber, rate responsive pacemaker/defibrillator system in Europe. The device incorporates Active Can technology as well as Medtronic's PR Logic dual chamber detection algorithm to discriminate between fast ventricular rhythms that are life-threatening and fast atrial arrhythmias that are not. At 62 cc, the 35 joule GEM DR is the world's smallest defibrillator and is anticipated to last seven to nine years under typical use conditions. A May 8 premarket approval application submission is pending at FDA for the device
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.